Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Riera

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal for Immunotherapy of Cancer|July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancerAlexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Frontiers in Oncology|January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancerJoseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Cancers|September 23, 2022
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor BoardThomas S Tarawneh, Fiona R Rodepeter, Julia Teply-Szymanski, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
BMC Cancer|December 29, 2017
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGISalah-Eddin Al-Batran, Thorsten O Goetze, Daniel W Mueller, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal for Immunotherapy of Cancer|July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancerAlexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Frontiers in Oncology|January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancerJoseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Cancers|September 23, 2022
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor BoardThomas S Tarawneh, Fiona R Rodepeter, Julia Teply-Szymanski, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
BMC Cancer|December 29, 2017
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGISalah-Eddin Al-Batran, Thorsten O Goetze, Daniel W Mueller, et al.
Pageof 8